Thus, it was shown that BSMS1 markedly activates both miR-146a and miR-146b expression in breast carcinoma cells and, through this mechanism, inhibits EGFR expression, thus leading to a reduced metastatic potential of these cells [7]. The gene discussed is EGFR; the disease is breast carcinoma.